Literature DB >> 32563551

Corrigendum to "Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents" [J Hosp Infect 104 (2020) 246-251].

G Kampf1, D Todt2, S Pfaender2, E Steinmann2.   

Abstract

Entities:  

Year:  2020        PMID: 32563551      PMCID: PMC7834866          DOI: 10.1016/j.jhin.2020.06.001

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


× No keyword cloud information.
A few details in our Review require clarification or amendment. We described 0.5% hydrogen peroxide in various parts of the manuscript to be effective against human coronaviruses in 1 min based on the study by Omidbaksh et al. [34]. In this study however, the test product was described as hydrogen peroxide-based but in an accelerated form (ACCEL TB from Virox Technologies Inc.). The formulation contains “very low levels of food-grade anionic and nonionic surfactants” in addition to 0.5% hydrogen peroxide. These are expected to “act in synergy with hydrogen peroxide to produce the desired microbiocidal activity”. Based on the US patent 6,346,279 referenced by Omidbaksh et al. “the solution also contains from 0.1 to 5.0% of at least one acid compound, e.g. phosphoric and/or a phosphonate with from 1 to 5 phosphonic acid groups, and from 0.02 to 5% of at least one anionic surfactant”. The exact composition of the formulation remains unknown. The product safety data sheet provided by the manufacturer of the product, however, declares only one active ingredient which is 0.5% hydrogen peroxide. Neither the article by Omidbakhsh et al., nor the above-mentioned patent, describe any comparative data for 0.5% hydrogen peroxide with and without acceleration. We are not able to evaluate if the acceleration significantly contributes to the virucidal activity of 0.5% hydrogen peroxide although it is plausible. Thus the results on 0.5% hydrogen peroxide described in our review can only be attributed to 0.5% hydrogen peroxide in an accelerated form. In addition, we want to clarify the description of the concentrations of alcohols more specifically. For ethanol it is always w/w except for 80% [v/v: reference 14] and 70% [unknown if v/v or w/w; reference 30]. For 2-propanol it is always w/w except 75% [v/v; reference 14] and 70% and 50% [unknown if v/v or w/w; references 28 and 30]. The mixture of 1-propanol and 2-propanol is w/w [references 28 and 29]. Finally, in the Discussion, the sentence “In an observational study, it was described that students touch their face with their own hands on average 23 times per h, with contact mostly to the skin (56%), followed by mouth (36%), nose (31%) and eyes (31%)” should have read “In an observational study, it was described that students touch their face with their own hands on average 23 times per h, with contact mostly to the skin (56%), followed by mouth (16%), nose (14%) and eyes (12%).”
  18 in total

1.  Proposal for the return to routine endoscopy during the COVID-19 pandemic.

Authors:  Sunil Gupta; Neal Shahidi; Nicole Gilroy; Douglas K Rex; Nicholas G Burgess; Michael J Bourke
Journal:  Gastrointest Endosc       Date:  2020-04-28       Impact factor: 9.427

2.  Disposable masks: Disinfection and sterilization for reuse, and non-certified manufacturing, in the face of shortages during the COVID-19 pandemic.

Authors:  Juan Carlos Rubio-Romero; María Del Carmen Pardo-Ferreira; Juan Antonio Torrecilla-García; Santiago Calero-Castro
Journal:  Saf Sci       Date:  2020-05-13       Impact factor: 4.877

Review 3.  Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19).

Authors:  Kalthoum Tizaoui; Ines Zidi; Keum Hwa Lee; Ramy Abou Ghayda; Sung Hwi Hong; Han Li; Lee Smith; Ai Koyanagi; Louis Jacob; Andreas Kronbichler; Jae Il Shin
Journal:  Int J Biol Sci       Date:  2020-09-12       Impact factor: 6.580

4.  A comparative analysis of control measures on-board ship against COVID-19 and similar novel viral respiratory disease outbreak: Quarantine ship or disembark suspects?

Authors:  Arun Gupta; Renuka Kunte; Neeti Goyal; Sougat Ray; Kamalpreet Singh
Journal:  Med J Armed Forces India       Date:  2020-06-30

Review 5.  An updated min-review on environmental route of the SARS-CoV-2 transmission.

Authors:  Edris Hoseinzadeh; Mahdi Farzadkia; Farshid Mohammadi; Hooshyar Hossini; Mahmoud Taghavi
Journal:  Ecotoxicol Environ Saf       Date:  2020-07-09       Impact factor: 6.291

6.  Investigating hypothiocyanite against SARS-CoV-2.

Authors:  L Cegolon
Journal:  Int J Hyg Environ Health       Date:  2020-04-06       Impact factor: 5.840

7.  Aerosol prevention in osteosynthesis for maxillofacial trauma - a technical note.

Authors:  J Grant; A Shafi; M Halsnad
Journal:  Br J Oral Maxillofac Surg       Date:  2020-05-06       Impact factor: 1.651

8.  Microbicidal actives with virucidal efficacy against SARS-CoV-2.

Authors:  M Khalid Ijaz; Kelly Whitehead; Vanita Srinivasan; Julie McKinney; Joseph R Rubino; Mark Ripley; Chris Jones; Raymond W Nims; Bruce Charlesworth
Journal:  Am J Infect Control       Date:  2020-05-24       Impact factor: 2.918

9.  Good Practice Recommendations from the Brazilian Society of Nephrology to Dialysis Units Concerning the Pandemic of the New Coronavirus (Covid-19).

Authors:  José A Moura-Neto; Andrea Pio de Abreu; Vinicius Daher Alvares Delfino; Ana Maria Misael; Ronaldo D'Avila; Dirceu Reis da Silva; Maria Claudia Cruz Andreoli; Angiolina Kraychete; Kleyton Bastos; Marcelo Mazza do Nascimento
Journal:  J Bras Nefrol       Date:  2020-08-26

10.  Hepatitis B virus detected in paper currencies in a densely populated city of India: A plausible source of horizontal transmission?

Authors:  Palashpriya Das; Ruchi Supekar; Ritika Chatterjee; Subrata Roy; Anisa Ghosh; Subhajit Biswas
Journal:  World J Hepatol       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.